Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
bioAffinity Technologies, Inc. ( (BIAF) ) has issued an announcement.
On October 7, 2025, bioAffinity Technologies announced a significant increase in sales of its CyPath® Lung diagnostic test for lung cancer, with a 95% rise in the third quarter of 2025 compared to the previous quarter. This growth is attributed to increased adoption by Veterans’ hospitals and expansion in the mid-Atlantic region. The test’s ability to detect early-stage lung cancer and prevent unnecessary invasive procedures has boosted physician confidence and integration into clinical practice, leading to a 77% increase in new patient usage. The company’s advancements highlight its strengthening position in the diagnostic market and its positive impact on patient care.
The most recent analyst rating on (BIAF) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on bioAffinity Technologies, Inc. stock, see the BIAF Stock Forecast page.
Spark’s Take on BIAF Stock
According to Spark, TipRanks’ AI Analyst, BIAF is a Underperform.
The overall stock score is primarily driven by the company’s weak financial performance and bearish technical indicators. The negative P/E ratio and lack of dividend yield further contribute to the low score. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on BIAF stock, click here.
More about bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. is a biotechnology company focused on developing noninvasive diagnostics for lung cancer and other lung diseases. Their primary product, CyPath® Lung, is a noninvasive test with high sensitivity, specificity, and accuracy for early-stage lung cancer detection. It is marketed as a Laboratory Developed Test by Precision Pathology Laboratory Services, a subsidiary of the company.
Average Trading Volume: 1,829,061
Technical Sentiment Signal: Sell
Current Market Cap: $4.75M
Find detailed analytics on BIAF stock on TipRanks’ Stock Analysis page.